Skip to main content
AIMD
NASDAQ Technology

Ainos 10-Q: Going-Concern Warning and Nasdaq Equity Deficiency Disclosed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.1
Mkt Cap
$9.938M
52W Low
$0.434
52W High
$3.88
52W Position info
153% above low
Off High info
72% below high
Rel. Volume info
12× avg
Market data snapshot near publication time

AIMD has more than doubled off its 52-week low of $0.434 on elevated volume (12× avg).

Summary

Ainos' Q3 10-Q confirms the $642,889 revenue already reported, but newly discloses substantial going-concern doubt and stockholders' equity of $1.72M — below Nasdaq's $2.5M minimum — with just $660,916 of cash on hand.


Key Events · Earnings and Guidance · AIMD

  • Going-Concern Doubt Disclosed

    The 10-Q states substantial doubt exists about the company's ability to continue as a going concern for at least one year from issuance, citing an accumulated deficit of $76,460,933 and expected continued losses.

  • Nasdaq Equity Requirement Shortfall

    Stockholders' equity of $1,721,037 at September 30, 2026 is below the $2,500,000 minimum required by Nasdaq Listing Rule 5550(b)(1), creating delisting risk if not cured or offset by an alternative standard.

  • Thin Liquidity vs. Current Liabilities

    Cash was $660,916 against $16,594,900 of total current liabilities, including $11,000,000 of convertible notes now classified current and a $2,812,940 loan payable.

  • Q3 Revenue Mostly One-Time License

    Revenue of $642,889 included a $600,000 one-time VELDONA license fee and $42,750 from AI Nose; net loss narrowed to $1,886,074 from $2,931,702 a year earlier.


Analysis · AIMD · Technology

The Q3 numbers were already out this morning, but the full 10-Q carries two items the headline release did not: management states substantial doubt exists about the company's ability to continue as a going concern, and stockholders' equity of $1.72M sits below Nasdaq's $2.5M minimum. With only $660,916 of cash against $16.6M of current liabilities, the company is dependent on continued ATM sales and its ASE relationship to fund operations. The near-term offsets are the $9M ASE AI Nose order signed November 12 and the $950,000 of receivables collected after quarter-end.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AIMD was trading at $1.10 on NASDAQ in the Technology sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $0.43 to $3.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AIMD - Latest Insights

AIMD
Nov 16, 2026, 8:41 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.32
Real-time Price: $1.06 info
Change: -$0.255 (-19%) info
Market Cap: $9.938M info
AIMD
Nov 16, 2026, 8:30 AM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $1.30
Real-time Price: $1.06 info
Change: -$0.240 (-18%) info
Market Cap: $9.938M info
AIMD
Nov 12, 2026, 8:30 AM EST
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.520
Real-time Price: $1.06 info
Change: +$0.540 (+104%) info
Market Cap: $9.938M info
AIMD
Nov 10, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.4693
Real-time Price: $1.06 info
Change: +$0.5907 (+126%) info
Market Cap: $9.938M info
AIMD
Sep 28, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.39
Real-time Price: $1.06 info
Change: -$0.328 (-24%) info
Market Cap: $9.938M info